Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ).
Jubilant Pharmova Limited has disclosed the transcript of its recent Investors and Analyst Meet, held on February 24, 2025, in compliance with SEBI regulations. This disclosure is part of the company’s ongoing efforts to maintain transparency with its stakeholders and provide insights into its strategic direction and financial performance.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is known for its commitment to innovation and quality in serving the healthcare sector.
YTD Price Performance: -16.49%
Average Trading Volume: 23,459
Current Market Cap: 143.7B INR
For an in-depth examination of JUBLPHARMA stock, go to TipRanks’ Stock Analysis page.